期刊文献+

腹腔镜微波消融术联合肝动脉化疗栓塞治疗中晚期肝癌的疗效分析 被引量:8

Transarterial chemoembolization combined with laparoscopic microwave ablation for advanced hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨腹腔镜微波消融术联合肝动脉化疗栓塞(TACE)治疗中晚期肝癌的临床应用。方法回顾性分析温州市人民医院2014年1月至2018年12月收治的中晚期肝癌患者90例,分为腹腔镜微波消融术联合TACE组(研究组,46例)和单纯TACE组(对照组,44例),比较两组的疗效及不良反应。结果与对照组比,研究组的客观有效率(37.0%vs 13.6%,P<0.05)和疾病控制率(80.4%vs 61.4%,P<0.05),首次治疗效果有优势。研究组1年生存率(69.6%vs 43.5%,P=0.012)和2年生存率(39.1%vs 27.8%,P=0.027),研究组的治疗效果优于对照组。AFP≥400 ng/L、PIVKA-II≥40μg/L、肿瘤多发、治疗方案、首次治疗效果是影响预后的独立危险因素。两组病例首次治疗后,均未发生严重不良反应及围术期死亡。结论腹腔镜微波消融术联合TACE治疗中晚期肝癌近期疗效好,生存期延长,严重不良反应发生率低,是一种安全、有效的治疗方案。 Objective To evaluate the efficacy and safety of transarterial chemoembolization(TACE)combined with Laparoscopic microwave ablation(LMWA)in patients with advanced hepatocellular carcinoma.Methods A total of 90 patients with advanced hepatocellular carcinoma admitted to Wenzhou People’Hospital from Jan.2014 to Dec.2018 were enrolled in this study and the clinical data were analyzed retrospectively.The patients were divided into study group(46 patients who underwent TACE combined with LWMA)and control group(44 patients who underwent TACE)according to treatment method.The treatment efficacy and adverse reactions of the two groups were compared.Results There was no statistical difference in general information between two groups.The effective rates of the study group and control group were 37.0%and 13.6%,the diease control rates were 80.4%and 61.4%.The 1-year survival rate was 69.6%and 43.5%(P=0.012),and the 2-year survival rate was 39.1%and 27.8%(P=0.027).Treatment effect in the study group was better than that in control group.AEP≥400 ng/L,PIVKA-II≥40μg/L,multiple tumors,choice of treatment plan and first treatment effect were independent risk factors affecting prognosis.No serious adverse reaction or perioperative death occurred in both groups after the first treatment.Conclusion In comparison with TACE alone,TACE combined with LWMA has good short-term curative effect,with prolonged survival period and low incidence of serious adeverse reactions,which is an effective and safe treatment plan.
作者 尤孙武 林祥 胡逸人 潘江华 童晓春 徐智锋 郑志强 YOU Sun-wu;LIN Xiang;HU Yi-ren;PAN Jiang-hua;TONG Xiao-chun;XU Zhi-feng;ZHENG Zhi-qiang(Department of Gastrointestinal Surgery,The Second Affiliated Hospital of Wenzhou Medical University,Zhejiang 325027,China;Department of General Surgery,Wenzhou People’s Hospital,Zhejiang 325000,China;Department of Traditional Chinese Medicine,Wenzhou People’s Hospital,Zhejiang 325000,China)
出处 《肝胆胰外科杂志》 CAS 2020年第9期526-531,共6页 Journal of Hepatopancreatobiliary Surgery
基金 温州市科技局项目(Y20170426)。
关键词 中晚期肝癌 腹腔镜下微波消融 肝动脉化疗栓塞 advanced hepatocellular carcinoma laparoscopic microwave ablation transcatheter arterial chemoembolization
  • 相关文献

参考文献7

二级参考文献72

  • 1殷晓煜,谢晓燕,吕明德,陈俊伟,徐辉雄,徐作峰,刘广健,黄蓓.超声引导经皮复合热消融技术治疗中、大肝细胞癌[J].中华外科杂志,2004,42(17):1029-1032. 被引量:20
  • 2董宝玮,梁萍,于晓玲,于德江,张晶,冯蕾,程志刚,王旸,王知力.超声引导经皮微波消融治疗早期原发性肝癌的远期疗效[J].中华医学杂志,2006,86(12):797-800. 被引量:78
  • 3Bruix J, Sherman M. Management of hepatoceUular carcinoma. Hepatology, 2005, 42 : 1208-1236.
  • 4Franco D, Capussotti L, Smadja C, et al. Resection of hepatocellular carcinoma: results in 72 European palients with cirrhosis. Gastroenterology, 1990, 98:733-738.
  • 5Nagorney DM, van Heerden JA, Ilstrup DM, et al. Primary hepatic malignancy: surgical management and determinants of survival. Surgery, 1989, 106:740-748.
  • 6Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg, 1999, 229 : 790-799.
  • 7Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer,1994,74:817-825.
  • 8Xu HX, Xie XY, Lu MD, et al. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol, 2004,59:53-61.
  • 9Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomised, double-blind, placebo-controlled trial. Lancet Oncol, 2009,10 : 25-34.
  • 10Goldberg SN,Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma.J Clin Gastroenterol,2002,35 (5 Suppl 2) :S115-129.

共引文献495

同被引文献66

引证文献8

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部